Detalhe da pesquisa
1.
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers.
Immunity
; 55(3): 557-574.e7, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263570
2.
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.
Nature
; 571(7764): 211-218, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207603
3.
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.
Nature
; 545(7652): 60-65, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28397821
4.
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours.
Br J Cancer
; 119(10): 1200-1207, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30318516
5.
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.
Nat Med
; 25(3): 454-461, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30804515
6.
Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma.
Oncoimmunology
; 7(10): e1468956, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30288340